Cargando…

Structural insights into pink-eyed dilution protein (Oca2)

Recent innovations in computational structural biology have opened an opportunity to revise our current understanding of the structure and function of clinically important proteins. This study centres on human Oca2 which is located on mature melanosomal membranes. Mutations of Oca2 can result in a f...

Descripción completa

Detalles Bibliográficos
Autores principales: Mesdaghi, Shahram, Murphy, David L., Simpkin, Adam J., Rigden, Daniel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372470/
https://www.ncbi.nlm.nih.gov/pubmed/37431738
http://dx.doi.org/10.1042/BSR20230060
_version_ 1785078384072589312
author Mesdaghi, Shahram
Murphy, David L.
Simpkin, Adam J.
Rigden, Daniel J.
author_facet Mesdaghi, Shahram
Murphy, David L.
Simpkin, Adam J.
Rigden, Daniel J.
author_sort Mesdaghi, Shahram
collection PubMed
description Recent innovations in computational structural biology have opened an opportunity to revise our current understanding of the structure and function of clinically important proteins. This study centres on human Oca2 which is located on mature melanosomal membranes. Mutations of Oca2 can result in a form of oculocutanous albinism, which is the most prevalent and visually identifiable form of albinism. Sequence analysis predicts Oca2 to be a member of the SLC13 transporter family, but it has not been classified into any existing SLC families. The modelling of Oca2 with AlphaFold2 and other advanced methods show that, like SLC13 members, it consists of a scaffold and transport domain and displays a pseudo inverted repeat topology that includes re-entrant loops. This finding contradicts the prevailing consensus view of its topology. In addition to the scaffold and transport domains, the presence of a cryptic GOLD domain is revealed that is likely responsible for its trafficking from the endoplasmic reticulum to the Golgi prior to localisation at the melanosomes. The GOLD domain harbours some known glycosylation sites. Analysis of the putative ligand binding site of the model shows the presence of highly conserved key asparagine residues that suggest Oca2 may be a Na(+)/dicarboxylate symporter. Known critical pathogenic mutations map to structural features present in the repeat regions that form the transport domain. Exploiting the AlphaFold2 multimeric modelling protocol in combination with conventional homology modelling allowed the building of plausible homodimers in both inward- and outward-facing conformations, supporting an elevator-type transport mechanism.
format Online
Article
Text
id pubmed-10372470
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Portland Press Ltd.
record_format MEDLINE/PubMed
spelling pubmed-103724702023-07-28 Structural insights into pink-eyed dilution protein (Oca2) Mesdaghi, Shahram Murphy, David L. Simpkin, Adam J. Rigden, Daniel J. Biosci Rep Bioinformatics Recent innovations in computational structural biology have opened an opportunity to revise our current understanding of the structure and function of clinically important proteins. This study centres on human Oca2 which is located on mature melanosomal membranes. Mutations of Oca2 can result in a form of oculocutanous albinism, which is the most prevalent and visually identifiable form of albinism. Sequence analysis predicts Oca2 to be a member of the SLC13 transporter family, but it has not been classified into any existing SLC families. The modelling of Oca2 with AlphaFold2 and other advanced methods show that, like SLC13 members, it consists of a scaffold and transport domain and displays a pseudo inverted repeat topology that includes re-entrant loops. This finding contradicts the prevailing consensus view of its topology. In addition to the scaffold and transport domains, the presence of a cryptic GOLD domain is revealed that is likely responsible for its trafficking from the endoplasmic reticulum to the Golgi prior to localisation at the melanosomes. The GOLD domain harbours some known glycosylation sites. Analysis of the putative ligand binding site of the model shows the presence of highly conserved key asparagine residues that suggest Oca2 may be a Na(+)/dicarboxylate symporter. Known critical pathogenic mutations map to structural features present in the repeat regions that form the transport domain. Exploiting the AlphaFold2 multimeric modelling protocol in combination with conventional homology modelling allowed the building of plausible homodimers in both inward- and outward-facing conformations, supporting an elevator-type transport mechanism. Portland Press Ltd. 2023-07-25 /pmc/articles/PMC10372470/ /pubmed/37431738 http://dx.doi.org/10.1042/BSR20230060 Text en © 2023 The Author(s). https://creativecommons.org/licenses/by/4.0/This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) (https://creativecommons.org/licenses/by/4.0/) . Open access for this article was enabled by the participation of University of Liverpool in an all-inclusive Read & Publish agreement with Portland Press and the Biochemical Society under a transformative agreement with JISC.
spellingShingle Bioinformatics
Mesdaghi, Shahram
Murphy, David L.
Simpkin, Adam J.
Rigden, Daniel J.
Structural insights into pink-eyed dilution protein (Oca2)
title Structural insights into pink-eyed dilution protein (Oca2)
title_full Structural insights into pink-eyed dilution protein (Oca2)
title_fullStr Structural insights into pink-eyed dilution protein (Oca2)
title_full_unstemmed Structural insights into pink-eyed dilution protein (Oca2)
title_short Structural insights into pink-eyed dilution protein (Oca2)
title_sort structural insights into pink-eyed dilution protein (oca2)
topic Bioinformatics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372470/
https://www.ncbi.nlm.nih.gov/pubmed/37431738
http://dx.doi.org/10.1042/BSR20230060
work_keys_str_mv AT mesdaghishahram structuralinsightsintopinkeyeddilutionproteinoca2
AT murphydavidl structuralinsightsintopinkeyeddilutionproteinoca2
AT simpkinadamj structuralinsightsintopinkeyeddilutionproteinoca2
AT rigdendanielj structuralinsightsintopinkeyeddilutionproteinoca2